Metabolomic applied to omalizumab effect in severe asthmatics – a preliminary result
نویسندگان
چکیده
Background Omalizumab is a recombinant monoclonal anti-immunoglobulin (Ig)E antibody (Ab), approved for treatment of severe asthma. The mechanisms by which is effective in asthma control are not yet fully understood but is known that it has an anti-inflammatory effect conducting to important clinical benefits. Urine sample collection is the least invasive form for biofluid sampling. The analysis of metabolomic urine profile in asthmatic patients undergoing omalizumab may add important data to the current knowledge.
منابع مشابه
Benefits of omalizumab on anxiety and depression in patients with severe asthma
Background: Asthma is one of the most common chronic diseases and may cause psychiatric disorders affecting the patients’ quality of life. In our study, we evaluated the effect of omalizumab treatment on anxiety disorder and depression using Beck Depression Scale (BDS) and State Trait Anxiety Inventory (STAI). Methods: Anxiety level was determined with STAI, whereas depression level was ...
متن کاملThe anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics.
The clinical benefit and steroid-sparing effect of treatment with the anti-immunoglobulin-E (IgE) antibody, omalizumab, was assessed in patients with moderate-to-severe allergic asthma. After a run-in period, 546 allergic asthmatics (aged 12-76 yrs), symptomatic despite inhaled corticosteroids (500-1,200 microg daily of beclomethasone dipropionate), were randomized to receive double-blind eithe...
متن کاملInfluence of the diagnosis chronic rhinosinusitis on asthma response to omalizumab in severe, uncontrolled asthmatics
Background Omalizumab is a humanized anti-immunoglobulin E (IgE) monoclonal antibody that has been approved as add-on therapy for the treatment of adults with moderate-tosevere (United States) or severe (Europe) allergic asthma, inadequately controlled after treatment with high-dose inhaled corticosteroids plus long-acting b-agonists. The clinical efficacy of Omalizumab has not only been shown ...
متن کاملThe real world effect of omalizumab add on therapy for patients with moderate to severe allergic asthma: The ASTERIX Observational study
BACKGROUND Omalizumab is a non-steroidal medication indicated for the treatment of poorly controlled moderate-to-severe allergic asthmatics. This observational study examines the "real world" effectiveness of omalizumab in this population. METHODS This is a one year open-label observational study that compared clinical outcomes including total oral corticosteroid use, exacerbation history, me...
متن کاملPediatric severe asthma: a case series report and perspectives on anti-IgE treatment
BACKGROUND The primary goal of asthma management is to achieve disease control for reducing the risk of future exacerbations and progressive loss of lung function. Asthma not responding to treatment may result in significant morbidity. In many children with uncontrolled symptoms, the diagnosis of asthma may be wrong or adherence to treatment may be poor. It is then crucial to distinguish these ...
متن کامل